135 related articles for article (PubMed ID: 11102415)
1. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997).
Granizo JJ; Aguilar L; Casal J; Dal-Ré R; Baquero F
J Antimicrob Chemother; 2000 Dec; 46(6):959-64. PubMed ID: 11102415
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain.
García-Rey C; Aguilar L; Baquero F; Casal J; Martín JE
J Clin Microbiol; 2002 Aug; 40(8):2959-63. PubMed ID: 12149359
[TBL] [Abstract][Full Text] [Related]
3. [Disappearance of Streptococcus pyogenes macrolide resistance in an area of northeastern Italy: a possible link with rational long-acting macrolide consumption].
De Rosa R; Avolio M; Stano P; Modolo ML; Camporese A
Infez Med; 2009 Jun; 17(2):82-7. PubMed ID: 19602920
[TBL] [Abstract][Full Text] [Related]
4. Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin.
Urbánek K; Kolár M; Cekanová L
Pharm World Sci; 2005 Apr; 27(2):104-7. PubMed ID: 15999920
[TBL] [Abstract][Full Text] [Related]
5. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997).
Granizo JJ; Aguilar L; Casal J; García-Rey C; Dal-Ré R; Baquero F
J Antimicrob Chemother; 2000 Nov; 46(5):767-73. PubMed ID: 11062196
[TBL] [Abstract][Full Text] [Related]
6. Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region.
Montagnani F; Stolzuoli L; Croci L; Rizzuti C; Arena F; Zanchi A; Cellesi C
Infection; 2009 Aug; 37(4):353-7. PubMed ID: 19137242
[TBL] [Abstract][Full Text] [Related]
7. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.
Bergman M; Huikko S; Pihlajamäki M; Laippala P; Palva E; Huovinen P; Seppälä H;
Clin Infect Dis; 2004 May; 38(9):1251-6. PubMed ID: 15127336
[TBL] [Abstract][Full Text] [Related]
8. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
9. Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.
Alós JI; Aracil B; Oteo J; Gómez-Garcés JL;
J Antimicrob Chemother; 2003 Feb; 51(2):333-7. PubMed ID: 12562699
[TBL] [Abstract][Full Text] [Related]
10. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
Morosini MI; Cantón R; Loza E; del Campo R; Almaraz F; Baquero F
J Antimicrob Chemother; 2003 Jul; 52(1):50-5. PubMed ID: 12805254
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).
Ardanuy C; Domenech A; Rolo D; Calatayud L; Tubau F; Ayats J; Martín R; Liñares J
J Antimicrob Chemother; 2010 Apr; 65(4):634-43. PubMed ID: 20118164
[TBL] [Abstract][Full Text] [Related]
12. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates.
Klugman KP; Capper T; Widdowson CA; Koornhof HJ; Moser W
J Antimicrob Chemother; 1998 Dec; 42(6):729-34. PubMed ID: 10052895
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.
Alós JI; Aracil B; Oteo J; Torres C; Gómez-Garcés JL
J Antimicrob Chemother; 2000 May; 45(5):605-9. PubMed ID: 10797081
[TBL] [Abstract][Full Text] [Related]
14. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004.
Tamayo J; Pérez-Trallero E; Gómez-Garcés JL; Alós JI;
J Antimicrob Chemother; 2005 Oct; 56(4):780-2. PubMed ID: 16120627
[TBL] [Abstract][Full Text] [Related]
15. [Resistance to macrolides in the species Streptococcus pyogenes in the Czech Republic in 1996-2003].
Urbásková P; Jakubů V;
Epidemiol Mikrobiol Imunol; 2004 Nov; 53(4):196-202. PubMed ID: 15633541
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.
Giovanetti E; Montanari MP; Marchetti F; Varaldo PE
J Antimicrob Chemother; 2000 Dec; 46(6):905-8. PubMed ID: 11102408
[TBL] [Abstract][Full Text] [Related]
17. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
[TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan.
Hsueh PR; Teng LJ; Lee LN; Yang PC; Ho SW; Lue HC; Luh KT
Microb Drug Resist; 2002; 8(1):27-33. PubMed ID: 12002646
[TBL] [Abstract][Full Text] [Related]
19. Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction.
Billal DS; Hotomi M; Yamauchi K; Fujihara K; Tamura S; Kuki K; Sugita R; Endou M; Mukaigawa J; Yamanaka N
J Infect Chemother; 2004 Apr; 10(2):115-20. PubMed ID: 15160306
[TBL] [Abstract][Full Text] [Related]
20. Erythromycin resistance in Streptococcus pyogenes in Italy.
Bassetti M; Manno G; Collidà A; Ferrando A; Gatti G; Ugolotti E; Cruciani M; Bassetti D
Emerg Infect Dis; 2000; 6(2):180-3. PubMed ID: 10756153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
